Hancock Jaffe Laboratories, Inc.
(NASDAQ : HJLI)

( )
HJLI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
1.33%104.130.6%$434.28m
ABTAbbott Laboratories
0.86%85.510.8%$411.87m
TMOThermo Fisher Scientific Inc.
1.19%279.441.0%$385.43m
ALGNAlign Technology, Inc.
0.19%177.626.3%$351.79m
ISRGIntuitive Surgical, Inc.
0.01%495.502.4%$292.16m
BDXBecton, Dickinson and Company
1.23%251.381.1%$273.83m
SYKStryker Corporation
0.74%218.601.3%$235.92m
EWEdwards Lifesciences Corporation
1.46%222.541.2%$226.01m
BSXBoston Scientific Corporation
1.38%42.731.1%$214.52m
ZBHZimmer Biomet Holdings, Inc.
1.12%138.541.7%$205.23m
BAXBaxter International Inc.
1.04%87.871.7%$196.71m
ABMDABIOMED, Inc.
-0.36%192.313.3%$158.93m
DXCMDexCom, Inc.
-0.06%163.598.3%$152.97m
WATWaters Corporation
2.10%209.863.8%$119.29m
IDXXIDEXX Laboratories, Inc.
1.50%279.533.7%$112.11m

Company Profile

Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops biologic-based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.